首页 | 本学科首页   官方微博 | 高级检索  
检索        

苯甲酰脲类抗肿瘤β微管蛋白抑制剂药效团模型的构建与应用
引用本文:高丽梅,张胜华,易红,蒋建东,宋丹青.苯甲酰脲类抗肿瘤β微管蛋白抑制剂药效团模型的构建与应用[J].药学学报,2010,45(4):462-466.
作者姓名:高丽梅  张胜华  易红  蒋建东  宋丹青
作者单位:(中国医学科学院、北京协和医学院医药生物技术研究所, 北京 100050)
基金项目:国家自然科学基金资助项目(30371673); “重大新药创制”科技重大专项资助项目(2009ZX09301-003)
摘    要:采用Catalyst软件包, 选择抗急性淋巴白血病细胞系活性相差较大的2种结构类型的17个苯甲酰脲类β微管蛋白抑制剂化合物作为训练集, 经构象分析, 构建出最佳药效团模型, 该模型含有2个疏水中心 (HP) 和2个氢键受体 (HBA), 具有良好的活性预测能力 (RMS = 0.43, Correl = 0.98, Weight = 2.06, Config = 15.97), 有利于设计和改造具有新型结构的β微管蛋白抑制剂。

关 键 词:计算机辅助药物设计  β微管蛋白抑制剂  药效团模型

Construction and application of pharmacophore model of benzoylurea derivatives as β-tubulin inhibitors
GAO Li-mei,ZHANG Sheng-hua,YI Hong,JIANG Jian-dong,SONG Dan-qing.Construction and application of pharmacophore model of benzoylurea derivatives as β-tubulin inhibitors[J].Acta Pharmaceutica Sinica,2010,45(4):462-466.
Authors:GAO Li-mei  ZHANG Sheng-hua  YI Hong  JIANG Jian-dong  SONG Dan-qing
Institution:GAO Li-mei,ZHANG Sheng-hua,YI Hong,JIANG Jian-dong,SONG Dan-qing (Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences & Beijing Union Medical College,Beijing 100050,China)
Abstract:Ten pharmacophore models of β-tubulin inhibitors were established from the training set of   seventeen β-tubulin inhibitors (two categories) with comformer analysis by using the Catalyst software.  The optimal pharmacophore model with two hydrophobic units and two hydrogen bond acceptor units were confirmed (RMS = 0.43, Correl = 0.98, Weight = 2.06, Config = 15.97).  This pharmacophore model is able to predict the activity of known β-tubulin inhibitors and can be further used to identify structurally diverse compounds with higher activity.
Keywords:CADD  &beta  -tubulin inhibitor  pharmacophore model
本文献已被 CNKI 等数据库收录!
点击此处可从《药学学报》浏览原始摘要信息
点击此处可从《药学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号